Skip to main content
. Author manuscript; available in PMC: 2015 Oct 7.
Published in final edited form as: J Am Coll Surg. 2013 Oct 24;218(2):196–205. doi: 10.1016/j.jamcollsurg.2013.10.011

Table 3.

Cox Regression Analyses of Variables Associated with Survival after Liver-Directed Procedures for Patients with Fibrolamellar Carcinoma or Hepatocellular Carcinoma from 1998 to 2008

Prognostic factor Univariate
Multivariate
Hazard ratio 95% CI p Value Hazard ratio 95% CI p Value
Age > 58y 1.51 1.42–1.62 <0.001 1.41 1.32–1.51 <0.001*

Female sex 1.024 0.95–1.10 0.516

Year of diagnosis quartile

 1986–2001 Reference

 2002–2004 1.62 1.42–1.86 <0.001 1.74 1.52–1.99 <0.001*

 2005–2006 1.35 1.18–1.55 <0.001 1.35 1.18–1.55 <0.001*

 2007–2008 1.20 1.04–1.39 <0.001 1.15 1.01–1.33 0.049*

Race

 White Reference

 Asian/Pacific Islander 1.62 1.16–2.26 0.005 1.44 1.03–2.02 0.032*

 Black 1.52 1.09–2.14 0.014 1.23 0.88–1.74 0.217

 Other 2.05 1.45–2.90 <0.001 1.86 1.31–2.63 <0.001*

Regional disease 1.62 1.51–1.75 <0.001 1.55 1.44–1.66 <0.001*

Grade

 Well-differentiated Reference

 Moderately differentiated 1.20 1.09–1.32 <0.001 0.74 0.70–0.82 <0.001*

 Poorly differentiated 1.77 1.77–1.58 <0.001 0.96 0.89–1.05 0.399

 Undifferentiated 1.67 1.28–2.18 <0.001 1.40 1.25–1.56 <0.001*

 Unknown 1.44 1.32–1.58 <0.001 1.26 0.96–1.63 0.089

Liver-directed procedure

 Resection or hepatic transplant Reference

 Ablation only 1.52 1.67–1.92 <0.001 1.79 1.66–1.93 <0.001*

 Surgery, not otherwise specified 1.79 1.23–1.86 <0.001 1.39 1.13–1.71 0.002*

Hepatocellular carcinoma 1.69 1.23–2.32 0.001 1.65 1.20–2.28 0.002*
*

Significant.